Research explores transition metal complexes against Escherichia coli and Staphylococcus aureus, suggesting potential for medical use.
Using a 2-Amino pyrimidine and 4-nitrobenzoyl isothiocyanate , a novel ligand 4-nitro-N - (pyrimidin-2-ylcarbamothioyl) benzamide (L') has been created. A few of the ligand's transition metal complexes have been designed and described using the UV-vis spectra, FT-IR, magnetic susceptibilities, conductivity measurements, and atomic absorptions. The ligand was identified using C.H.N.S., UV-Vis, FT-IR, and 1 H, 13 CNMR spectra. The behavior of the ligand is comparable to that of a bidentate coordinating through atoms S and O. According to the data, the chemical formula of every complex created was [M(L)2Cl2] (M (II) = Mn, Co, Zn and Hg). An octahedral geometrical structure was proposed for each complex. Escherichia coli and Staphylococcus aureus are two microorganisms that the metal and ligand complexes show good activity against.
No takes yet. Share an insight, caveat, or question.
Fayyadh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: